CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
This is the first update to the original CTS communication distributed on July 6th. As previously co...